GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » EV-to-EBITDA

Cybin (CYBN) EV-to-EBITDA : -4.72 (As of May. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cybin EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cybin's enterprise value is $234.64 Mil. Cybin's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-49.74 Mil. Therefore, Cybin's EV-to-EBITDA for today is -4.72.

The historical rank and industry rank for Cybin's EV-to-EBITDA or its related term are showing as below:

CYBN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.81   Med: -1.53   Max: 0.52
Current: -4.81

During the past 4 years, the highest EV-to-EBITDA of Cybin was 0.52. The lowest was -16.81. And the median was -1.53.

CYBN's EV-to-EBITDA is ranked worse than
100% of 450 companies
in the Biotechnology industry
Industry Median: 9.57 vs CYBN: -4.81

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Cybin's stock price is $0.3561. Cybin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.208. Therefore, Cybin's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cybin EV-to-EBITDA Historical Data

The historical data trend for Cybin's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin EV-to-EBITDA Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
- -4.62 -1.81 -1.70

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -1.70 -1.88 -3.18 -2.64

Competitive Comparison of Cybin's EV-to-EBITDA

For the Biotechnology subindustry, Cybin's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cybin's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cybin's EV-to-EBITDA falls into.



Cybin EV-to-EBITDA Calculation

Cybin's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=234.638/-49.742
=-4.72

Cybin's current Enterprise Value is $234.64 Mil.
Cybin's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cybin  (AMEX:CYBN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cybin's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.3561/-0.208
=At Loss

Cybin's share price for today is $0.3561.
Cybin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.208.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cybin EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cybin's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.